title: Introduction: the rationale for the development of targeted drugs in cancer therapy.
authors.affiliation: Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt am Main, Germany. groner@em.uni-frankfurt.de
authors.forename: Bernd
authors.initials: B
authors.lastname: Groner
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents